The Efficacy and Tolerability of ABVD and Stanford V in Older Hodgkin Lymphoma Patients: A Comprehensive Analysis from the North American Intergroup Trial E2496

There is a lack of contemporary prospective data examining the ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) and Stanford V (SV; doxorubicin, vinblastine, mechlorethamine, vincristine, bleomycin, etoposide, prednisone) regimens in older Hodgkin lymphoma (HL) patients. Forty-four advanced-st...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Evens, Andrew M., Hong, Fangxin, Gordon, Leo I., Fisher, Richard I., Bartlett, Nancy L., Connors, Joseph M., Gascoyne, Randy D., Wagner, Henry, Gospodarowicz, Mary, Cheson, Bruce D., Stiff, Patrick J., Advani, Ranjana, Miller, Thomas P., Hoppe, Richard T., Kahl, Brad S., Horning, Sandra J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906856/
https://ncbi.nlm.nih.gov/pubmed/23356491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12222
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky